16/12/201526/01/2024 Helix BioPharma Corp. Announces The Results of Its Annual General Meeting admin 0 Comments
04/11/201526/01/2024 Helix BioPharma Corp. Initiates Enrollment for Fourteenth Cohort in Polish Phase I/II Clinical Study of Its L-DOS47 Lung Cancer Drug admin 0 Comments
30/09/201526/01/2024 Helix BioPharma Corp. Announces Appointment of A New Director and Leadership Transition Plans admin 0 Comments
08/09/201526/01/2024 Helix BioPharma Corp. Gives Presentation And Update of L‐DOS47 Clinical Study At World Conference On Lung Cancer admin 0 Comments